Brief: Aegirbio Signs R&D Agreement With MediaPharma

Subgen AI AB

13/10/2020 14:10

Oct 13 (Reuters) - Aegirbio AB  AEGIR.ST :
    * SIGNS RESEARCH AND DEVELOPMENT AGREEMENT WITH MEDIAPHARMA
    * SIGNED AGREEMENT WITH MEDIAPHARMA SRL, AN ITALIAN
BIOTECHNOLOGY
COMPANY THAT FOCUSES ON NEW DRUGS TO CURE CANCER
    * THROUGH THE AGREEMENT, CO INTENDS TO DEVELOP THESE DRUGS
TOGETHER WITH MEDIAPHARMA IN ONCOLOGY AND OTHER AREAS

Source text for Eikon:  ID:nWkr85LS9l 
Further company coverage:  AEGIR.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))